Largest pharmaceuticals by total liabilities
Everything the company owes, as its balance sheet stood at the end of the latest fiscal year.
AbbVie leads the 61 pharmaceuticals ranked by total liabilities, at CHF 115.7B, ahead of Pfizer (CHF 102.4B) and Johnson & Johnson (CHF 99.2B). Figures as of 18 Nov 2026, 14:08 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- AbbVieCHF 115.7B
- Median
- CHF 1.8B
- Combined market value
- CHF 4.35T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Total liabilities ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | AbbVieABBV · Health Care | CHF 115.7B | CHF 436.5B | CHF 246.97 | 0.59% down | 26% up | ||
| 2 | PfizerPFE · Health Care | CHF 102.4B | CHF 136.9B | CHF 24.01 | 1.35% down | 14% up | ||
| 3 | Johnson & JohnsonJNJ · Health Care | CHF 99.2B | CHF 565.9B | CHF 235.06 | 1.36% down | 38% up | ||
| 4 | Eli LillyLLY · Health Care | CHF 72.5B | CHF 1.06T | CHF 1,193.90 | 1.13% down | 35% up | ||
| 5 | Merck & CoMRK · Health Care | CHF 71B | CHF 298.1B | CHF 120.92 | 0.75% down | 51% up | ||
| 6 | Bristol-Myers SquibbBMY · Health Care | CHF 60.3B | CHF 105.8B | CHF 51.74 | 2.51% down | 34% up | ||
| 7 | AstraZenecaAZN · Health Care | CHF 55.1B | CHF 238.4B | CHF 153.73 | 0.95% down | 2% up | ||
| 8 | NovartisNVS · Health Care | CHF 54.3B | CHF 253.5B | CHF 134.21 | 0.67% down | 25% up | ||
| 9 | SanofiSNY · Health Care | CHF 51.6B | CHF 96.3B | CHF 40.09 | 1.78% down | 4% down | ||
| 10 | GSKGSK · Health Care | CHF 50.6B | CHF 83.2B | CHF 41.53 | 2.32% down | 6% up | ||
| 11 | Novo NordiskNVO · Health Care | CHF 43.7B | CHF 151.3B | CHF 34.33 | 2.16% down | 17% down | ||
| 12 | Takeda PharmaceuticalTAK · Health Care | CHF 42.7B | CHF 58.3B | CHF 18.25 | 0.23% up | 54% up | ||
| 13 | Abbott LaboratoriesABT · Health Care | CHF 28.6B | CHF 153B | CHF 88.31 | 2.55% down | 17% down | ||
| 14 | Teva Pharmaceutical IndustriesTEVA · Health Care | CHF 27.7B | CHF 41.9B | CHF 35.95 | 0.12% up | 74% up | ||
| 15 | ViatrisVTRS · Health Care | CHF 19B | CHF 19.8B | CHF 17.25 | 1.40% down | 96% up | ||
| 16 | GrifolsGRFS · Health Care | CHF 11.3B | CHF 5B | CHF 7.28 | 1.15% down | 1% up | ||
| 17 | ZoetisZTS · Health Care | CHF 10.2B | CHF 28.6B | CHF 70.41 | 1.08% down | 29% down | ||
| 18 | Royalty PharmaRPRX · Health Care | CHF 8.4B | CHF 33.3B | CHF 57.93 | 0.23% up | 78% up | ||
| 19 | Regeneron PharmaceuticalsREGN · Health Care | CHF 7.8B | CHF 83.6B | CHF 807.79 | 0.56% up | 36% up | ||
| 20 | Jazz PharmaceuticalsJAZZ · Health Care | CHF 6.2B | CHF 13B | CHF 203.02 | 0.39% up | 37% up | ||
| 21 | GenmabGMAB · Health Care | CHF 5.9B | CHF 27B | CHF 43.82 | 0.76% up | 70% up | ||
| 22 | Vertex PharmaceuticalsVRTX · Health Care | CHF 5.9B | CHF 114.2B | CHF 450.55 | 0.67% down | 27% up | ||
| 23 | Elanco Animal HealthELAN · Health Care | CHF 5.7B | CHF 10.9B | CHF 21.80 | 2.12% down | 20% up | ||
| 24 | Alnylam PharmaceuticalsALNY · Health Care | CHF 3.5B | CHF 17.7B | CHF 132.00 | 2.02% down | 66% down | ||
| 25 | BeOne MedicinesONC · Health Care | CHF 3.2B | CHF 39.8B | CHF 348.55 | 0.48% up | 17% up | ||
| 26 | Amneal PharmaceuticalsAMRX · Health Care | CHF 3.1B | CHF 6.2B | CHF 17.81 | 0.52% down | 83% up | ||
| 27 | PTC TherapeuticsPTCT · Health Care | CHF 2.6B | CHF 4.3B | CHF 50.91 | 1.00% down | 20% down | ||
| 28 | Ionis PharmaceuticalsIONS · Health Care | CHF 2.6B | CHF 3.8B | CHF 22.74 | 3.75% down | 64% down | ||
| 29 | BridgeBio PharmaBBIO · Health Care | CHF 2.5B | CHF 12.6B | CHF 64.77 | 0.72% down | 17% up | ||
| 30 | Dr. Reddy's LaboratoriesRDY · Health Care | CHF 1.8B | CHF 10.4B | CHF 12.47 | 0.61% up | 5% up | ||
| 31 | CytokineticsCYTK · Health Care | CHF 1.8B | CHF 6.1B | CHF 43.56 | 2.86% down | 20% down | ||
| 32 | Ascendis PharmaASND · Health Care | CHF 1.4B | CHF 15B | CHF 228.73 | 0.20% down | 28% up | ||
| 33 | InsmedINSM · Health Care | CHF 1.3B | CHF 22.5B | CHF 102.78 | 0.83% down | 40% down | ||
| 34 | BioMarin PharmaceuticalBMRN · Health Care | CHF 1.3B | CHF 9.6B | CHF 49.35 | 0.90% up | 11% up | ||
| 35 | Arrowhead PharmaceuticalsARWR · Health Care | CHF 743.8M | CHF 5.1B | CHF 36.26 | 2.76% down | 10% up | ||
| 36 | United TherapeuticsUTHR · Health Care | CHF 661.1M | CHF 21B | CHF 492.64 | 0.64% down | 23% up | ||
| 37 | Legend BiotechLEGN · Health Care | CHF 617M | CHF 2.6B | CHF 13.59 | 0.75% up | 42% down | ||
| 38 | AlkermesALKS · Health Care | CHF 563.1M | CHF 6.4B | CHF 38.33 | 2.32% down | 58% up | ||
| 39 | Madrigal PharmaceuticalsMDGL · Health Care | CHF 554M | CHF 8.3B | CHF 355.91 | 0.46% down | 24% down | ||
| 40 | Axsome TherapeuticsAXSM · Health Care | CHF 507.3M | CHF 6B | CHF 114.66 | 0.77% down | 7% down | ||
| 41 | Ligand PharmaceuticalsLGND · Health Care | CHF 458.3M | CHF 5B | CHF 247.81 | 2.62% down | 43% up | ||
| 42 | Mirum PharmaceuticalsMIRM · Health Care | CHF 445.4M | CHF 5.1B | CHF 77.55 | 0.40% up | 31% up | ||
| 43 | Travere TherapeuticsTVTX · Health Care | CHF 413.6M | CHF 4.1B | CHF 43.10 | 2.82% up | 44% up | ||
| 44 | Roivant SciencesROIV · Health Care | CHF 351.1M | CHF 23.7B | CHF 32.65 | 0.26% up | 90% up | ||
| 45 | TG TherapeuticsTGTX · Health Care | CHF 350.2M | CHF 8B | CHF 52.89 | 0.08% down | 107% up | ||
| 46 | Cogent BiosciencesCOGT · Health Care | CHF 254.1M | CHF 4.1B | CHF 23.49 | 1.49% up | 20% down | ||
| 47 | Rhythm PharmaceuticalsRYTM · Health Care | CHF 177.3M | CHF 6.8B | CHF 98.35 | 8.49% up | 13% up | ||
| 48 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | CHF 165.3M | CHF 6.3B | CHF 80.22 | 0.93% up | 126% up | ||
| 49 | Corcept TherapeuticsCORT · Health Care | CHF 159.3M | CHF 6.5B | CHF 59.10 | 1.23% up | 8% down | ||
| 50 | ABIVAXABVX · Health Care | CHF 120.8M | CHF 6.1B | CHF 69.24 | 1.81% down | 27% down | ||
| 51 | Definium TherapeuticsDFTX · Health Care | CHF 90.9M | CHF 3.4B | CHF 24.78 | 2.59% down | 169% up | ||
| 52 | Summit TherapeuticsSMMT · Health Care | CHF 77.9M | CHF 7.2B | CHF 9.00 | 9.73% down | 36% down | ||
| 53 | ErascaERAS · Health Care | CHF 59.9M | CHF 4.1B | CHF 11.72 | 8.07% down | 403% up | ||
| 54 | Spyre TherapeuticsSYRE · Health Care | CHF 52.8M | CHF 7.5B | CHF 79.12 | 5.60% down | 286% up | ||
| 55 | Praxis Precision MedicinesPRAX · Health Care | CHF 50.4M | CHF 7.2B | CHF 257.29 | 1.68% down | 61% up | ||
| 56 | Protagonist TherapeuticsPTGX · Health Care | CHF 45.1M | CHF 6.9B | CHF 105.15 | 0.13% down | 46% up | ||
| 57 | Dianthus TherapeuticsDNTH · Health Care | CHF 31.6M | CHF 4.1B | CHF 73.36 | 2.87% down | 113% up | ||
| 58 | Edgewise TherapeuticsEWTX · Health Care | CHF 25.6M | CHF 3.9B | CHF 35.46 | 3.75% down | 88% up | ||
| 59 | Oruka TherapeuticsORKA · Health Care | CHF 14.1M | CHF 5.5B | CHF 81.24 | 2.94% down | 241% up | ||
| 60 | Belite BioBLTE · Health Care | CHF 8.5M | CHF 5.4B | CHF 133.02 | 2.98% down | 31% up | ||
| 61 | VeradermicsMANE · Health Care | CHF 7.7M | CHF 4.5B | CHF 105.97 | 1.88% down | 233% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total liabilities is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Where a company reports no total-liabilities line, it is worked out as assets less equity. Sums are converted from US dollars at today's exchange rate (1 USD = 0.8434 CHF).
Questions and answers
Which pharmaceuticals rank first by total liabilities?
AbbVie (CHF 115.7B), Pfizer (CHF 102.4B) and Johnson & Johnson (CHF 99.2B) are the top three of the 61 pharmaceuticals ranked by total liabilities as of 18 Nov 2026, 14:08 UTC.
How many pharmaceuticals are in this ranking?
61 are ranked by total liabilities.
What are these pharmaceuticals worth together?
The 61 pharmaceuticals ranked by total liabilities have a combined market value of CHF 4.35T as of 18 Nov 2026, 14:08 UTC.
What does ranking by total liabilities measure?
Everything the company owes, as its balance sheet stood at the end of the latest fiscal year.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest pharmaceuticals by total liabilities”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=total-liabilities
Underlying data: Yahoo Finance; SEC EDGAR.